`
Thursday, 17 August 2017

Biologics News

  • Japanese nod for Janssen psoriatic arthritis drug

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2013

    Singapore: European Commission has approved Janssen-Cilag International's Stelara (ustekinumab), as a stand-alone drug or in combination with methotrexate, for the treatment of active psori...Read more

  • Chinese govt delay hinders GMP plant set up

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced that the construction of a new production facility at its Guizhou ...Read more

  • German firm gets EU patent for dsRNA modification

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2013

    Singapore: German company, Riboxx Pharmaceuticals, received patent from European Patent Office (EPO) on a novel process for the manufacturing of double-stranded RNA (dsRNA) bearing chemical...Read more

  • 3SBio acquires patents for kidney failure drug

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2013

    Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acquired patents for DJ5, a novel non-TZD PPARgamma agonist with potentia...Read more

  • Asia leverages on the biologics opportunity

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of active pharmaceutical ingredients, but they still need to build their s...Read more

  • Now remote monitoring service via smartphone

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2014

    Singapore: AB SCIEX, life science analytical technologies provider, has launched StatusScope Remote Monitoring service, a configurable, real-time offering that supports most AB SCIEX mass s...Read more

  • Agilent launches biology solution for protein analysis

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014

    Singapore: Global supplier firm, Agilent Technologies, has launched QuikChange HT Protein Engineering System, a novel synthetic biology solutions for rational mutagenesis that creates libra...Read more

  • Belgian doctors develop new test tube baby system

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013

    Singapore: As a solution to the lack of affordable test tube baby technology in developing countries, Belgian doctors have arrived at a solution. The researchers from Genk Institute for Fer...Read more

  • Monoclonal antibodies market set to grow in Europe

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Oct, 2012

    Singapore: Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies based therapeutics against conventional chemical drugs...Read more

  • Teva to acquire migraine drug firm at $825 mn

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014

    Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmaceutical, is set to acquire biotechnology company focused on treatment...Read more

  • Merck, Samsung to co-develop diabetes drug

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014

    Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, have expanded their collaboration  to develop, manufacture ...Read more

  • H7N9 antibodies high among poultry workers'

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014

    Singapore: Serological tests conducted on poultry workers of southern Guangdong province city of Shenzhen China, showed evidence of asymptomatic or mild infections in poultry workers, furth...Read more

  • Quintiles to advise Ascendancy on pharma deals in China

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013

    Singapore: San Francisco-based Ascendancy Healthcare has tied up with Quintiles to get help from the contract research giant in order to leverage on China's growing pharma market. Quintile...Read more

  • Scientists trace origin of skin-deep immune cells

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012

    Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful g...Read more

  • India's Polyclone collaborate with Greifswald Uni to engineer enzyme

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2014

    Singapore: India based Polyclone, a biotech company with expertise in molecular, cell and computational biology has collaborated with the Dept. of Biotechnology & Enzyme Catalysis of th...Read more

  • GE launches modular pharma factory

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012

    Singapore: GE Healthcare introduced KUBio, an innovative off-the-shelf, modular factory, designed to save manufacturers of biopharmaceuticals both time and money. KUBio's pre-made modules,...Read more

  • Green Cross builds $68 mn Thai plasma plant

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 13 Feb, 2013

    Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thailand. Green Cross, which signed the contract for the plant with the Th...Read more

  • Novozymes sales increased 7% in 2012

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2013

    Singapore: Novozymes reported seven percent sales growth in 2012 when compared with 2011. EBIT increased by 17 percent, raising the EBIT margin to 24.4 percent. Net profit grew by 10 percen...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls